InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by MCCORMICK FRANK. Officer active across 1 company, notably BridgeBio Pharma, Inc.. Cumulatively, 4 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €3.8m. History available since 26 December 2023. The latest transaction was filed on 7 May 2025 (Don). Regulator: SEC (Form 4). The full history is openly available.
4 of 4 declarations